225 related articles for article (PubMed ID: 21428704)
21. Development of colon targeted multiparticulate pulsatile drug delivery system for treating nocturnal asthma.
Kadam VD; Gattani SG
Drug Deliv; 2010 Jul; 17(5):343-51. PubMed ID: 20429842
[TBL] [Abstract][Full Text] [Related]
22. Protective efficacy of ursodeoxycholic acid nanoparticles in animal model of inflammatory bowel disease.
De AK; Sana S; Datta S; Mukherjee A
J Microencapsul; 2014; 31(8):725-37. PubMed ID: 24963957
[TBL] [Abstract][Full Text] [Related]
23. Bioadhesive pellets increase local 5-aminosalicylic acid concentration in experimental colitis.
Bautzová T; Rabišková M; Béduneau A; Pellequer Y; Lamprecht A
Eur J Pharm Biopharm; 2012 Jun; 81(2):379-85. PubMed ID: 22386911
[TBL] [Abstract][Full Text] [Related]
24. A novel double-coating approach for improved pH-triggered delivery to the ileo-colonic region of the gastrointestinal tract.
Liu F; Moreno P; Basit AW
Eur J Pharm Biopharm; 2010 Feb; 74(2):311-5. PubMed ID: 19932177
[TBL] [Abstract][Full Text] [Related]
25. Budesonide-Loaded Eudragit S 100 Nanocapsules for the Treatment of Acetic Acid-Induced Colitis in Animal Model.
Qelliny MR; Aly UF; Elgarhy OH; Khaled KA
AAPS PharmSciTech; 2019 Jun; 20(6):237. PubMed ID: 31243601
[TBL] [Abstract][Full Text] [Related]
26. Prednisolone-loaded nanocapsules as ocular drug delivery system: development, in vitro drug release and eye toxicity.
Katzer T; Chaves P; Bernardi A; Pohlmann A; Guterres SS; Ruver Beck RC
J Microencapsul; 2014; 31(6):519-28. PubMed ID: 24697184
[TBL] [Abstract][Full Text] [Related]
27. The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles.
Nilkumhang S; Basit AW
Int J Pharm; 2009 Jul; 377(1-2):135-41. PubMed ID: 19515519
[TBL] [Abstract][Full Text] [Related]
28. Coated hard capsules as the pH-dependent drug transport systems to ileo-colonic compartment.
Dvořáčková K; Rabišková M; Muselík J; Gajdziok J; Bajerová M
Drug Dev Ind Pharm; 2011 Oct; 37(10):1131-40. PubMed ID: 21417619
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and toxicity of Eudragit-coated chitosan-succinyl-prednisolone conjugate microspheres using rats with 2,4,6-trinitrobenzenesulfonic acid-induced colitis.
Onishi H; Oosegi T; Machida Y
Int J Pharm; 2008 Jun; 358(1-2):296-302. PubMed ID: 18394832
[TBL] [Abstract][Full Text] [Related]
30. Central composite design for the formulation and optimization of a multi-unit potential colonic drug delivery system of budesonide for ulcerative colitis.
Patel NV; Patel JK; Shah SH; Patel JN
Pharmazie; 2011 Feb; 66(2):124-9. PubMed ID: 21434575
[TBL] [Abstract][Full Text] [Related]
31. Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system.
Oosegi T; Onishi H; Machida Y
Eur J Pharm Biopharm; 2008 Feb; 68(2):260-6. PubMed ID: 17703928
[TBL] [Abstract][Full Text] [Related]
32. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
[TBL] [Abstract][Full Text] [Related]
33. Colon-targeted delivery of budesonide using dual pH- and time-dependent polymeric nanoparticles for colitis therapy.
Naeem M; Choi M; Cao J; Lee Y; Ikram M; Yoon S; Lee J; Moon HR; Kim MS; Jung Y; Yoo JW
Drug Des Devel Ther; 2015; 9():3789-99. PubMed ID: 26229440
[TBL] [Abstract][Full Text] [Related]
34. Formulation, evaluation and pharmacokinetics of colon targeted pulsatile system of flurbiprofen.
Veerareddy PR; Vemula SK
J Drug Target; 2012 Sep; 20(8):703-14. PubMed ID: 22845842
[TBL] [Abstract][Full Text] [Related]
35. Factorial design-based development of measlamine microspheres for colonic delivery.
Jain V; Prasad D; Jain D; Mishra SK; Singh R
Biomatter; 2011; 1(2):182-8. PubMed ID: 23507747
[TBL] [Abstract][Full Text] [Related]
36. Multiparticulate formulation approach to colon specific drug delivery: current perspectives.
Asghar LF; Chandran S
J Pharm Pharm Sci; 2006; 9(3):327-38. PubMed ID: 17207416
[TBL] [Abstract][Full Text] [Related]
37. Combination of time-dependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets.
Akhgari A; Sadeghi F; Garekani HA
Int J Pharm; 2006 Aug; 320(1-2):137-42. PubMed ID: 16782290
[TBL] [Abstract][Full Text] [Related]
38. Studies of chitosan/organic acid/Eudragit RS/RL-coated system for colonic delivery.
Kaur K; Kim K
Int J Pharm; 2009 Jan; 366(1-2):140-8. PubMed ID: 18835342
[TBL] [Abstract][Full Text] [Related]
39. [Optimization and evaluation of a new antischistosomal drug QH917 self-microemulsifying drug delivery system].
Zhang JY; Gan Y; Gan L; Zhu CL; Pan WS
Yao Xue Xue Bao; 2007 Apr; 42(4):434-9. PubMed ID: 17633215
[TBL] [Abstract][Full Text] [Related]
40. Enzyme/pH dual sensitive polymeric nanoparticles for targeted drug delivery to the inflamed colon.
Naeem M; Kim W; Cao J; Jung Y; Yoo JW
Colloids Surf B Biointerfaces; 2014 Nov; 123():271-8. PubMed ID: 25266978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
